Hospital-acquired pneumonia epidemiology and demographics

Jump to navigation Jump to search

Pneumonia Main Page

Hospital-acquired pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hospital-Acquired Pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hospital-acquired pneumonia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hospital-acquired pneumonia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hospital-acquired pneumonia epidemiology and demographics

CDC onHospital-acquired pneumonia epidemiology and demographics

Hospital-acquired pneumonia epidemiology and demographics in the news

Blogs on Hospital-acquired pneumonia epidemiology and demographics

Directions to Hospitals Treating Hospital-acquired pneumonia

Risk calculators and risk factors for Hospital-acquired pneumonia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

The epidemiology of health-care-associated pneumonia varies considerably according to the type of health-care setting. Nosocomial pneumonia has been the second most common hospital-associated infection after that of the urinary tract. The primary risk factor for the development of hospital-associated bacterial pneumonia is mechanical ventilation. In long-term care facilities such as nursing homes, pneumonia is the first or second most common infection (after those of the urinary tract) acquired by patients, and accounts for 13-48% of all nursing home-associated infections. [1]

Epidemiology and Demographics

  • Pneumonia has accounted for approximately 20% of all hospital-associated infections and 27% and 24% of all infections acquired in the medical intensive-care unit (ICU) and coronary care unit, respectively. [2]

Incidence

  • The incidence of HAP is 5-15 cases per 1 000 hospital admissions. [3]
  • The incidence of VAP is 6 to 20 times more than in patients without mechanical support.
Age Females Males
18-44 years 5% 4%
45-64 years 14% 13%
≥ 65 years 34% 30%
Total 53% 47%
Table adapted from 2009–2011 National Medicare Patient Safety Monitoring System [4]

Mortality

  • HAP and VAP are nosocomial infections with a high mortality in contrast with other nosocomial infections.
  • This higher mortality rate is associated with MDR pathogens.

Age

  • HAP is more commonly reported in patients > 65 years, probably due to the fact that this age population is more commonly hospitalized.

Gender

  • There is no predominance in gender, although some data reports a higher incidence among females.

Ventilator-associated Pneumonia

  • VAP occurs in up to 25% of all people who require mechanical ventilation.
  • VAP can develop at any time during ventilation, but occurs more often in the first few days after intubation.
  • This is because the intubation process itself contributes to the development of VAP.
  • VAP occurring early after intubation typically involves fewer resistant organisms and is thus associated with a more favorable outcome.
  • Because respiratory failure requiring mechanical ventilation is itself associated with a high mortality, determination of the exact contribution of VAP to mortality has been difficult.
  • As of 2006, estimates range from 33% to 50% death in patients who develop VAP.
  • Mortality is more likely when VAP is associated with certain microorganisms (Pseudomonas, Acinetobacter), blood stream infections, and ineffective initial antibiotics.
  • VAP is especially common in people who have acute respiratory distress syndrome (ARDS).


References

  1. "CDC GUIDELINES FOR PREVENTING HEALTH-CARE-ASSOCIATED PNEUMONIA, 2003" (PDF).
  2. Magill, Shelley S.; Edwards, Jonathan R.; Bamberg, Wendy; Beldavs, Zintars G.; Dumyati, Ghinwa; Kainer, Marion A.; Lynfield, Ruth; Maloney, Meghan; McAllister-Hollod, Laura; Nadle, Joelle; Ray, Susan M.; Thompson, Deborah L.; Wilson, Lucy E.; Fridkin, Scott K. (2014). "Multistate Point-Prevalence Survey of Health Care–Associated Infections". New England Journal of Medicine. 370 (13): 1198–1208. doi:10.1056/NEJMoa1306801. ISSN 0028-4793.
  3. "Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia". American Journal of Respiratory and Critical Care Medicine. 171 (4): 388–416. 2005. doi:10.1164/rccm.200405-644ST. ISSN 1073-449X.
  4. Eckenrode, Sheila; Bakullari, Anila; Metersky, Mark L.; Wang, Yun; Pandolfi, Michelle M.; Galusha, Deron; Jaser, Lisa; Eldridge, Noel (2014). "The Association between Age, Sex, and Hospital-Acquired Infection Rates: Results from the 2009–2011 National Medicare Patient Safety Monitoring System". Infection Control and Hospital Epidemiology. 35 (S3): S3–S9. doi:10.1086/677831. ISSN 0899-823X.

Template:WH Template:WS